Larimar Therapeutics (LRMR) Q4 2022 Earnings

14MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.57
-0.45
-0.33
-0.21

Details

Expected EPS
-0.37
Actual EPS
-0.21
Surprise EPS
0.16
Surprise Percent
+43.24%

Description

Larimar Therapeutics (LRMR) has reported earnings of -0.21 per share for Q4 2022.

0 Comments

Share your thoughts